These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. XELOX in colorectal cancer: a convenient option for the future? Lindsay CR; Cassidy J Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):9-19. PubMed ID: 21309667 [TBL] [Abstract][Full Text] [Related]
9. Trastuzumab and capecitabine for metastatic breast cancer. Med Lett Drugs Ther; 1998 Nov; 40(1039):106-8. PubMed ID: 9814369 [No Abstract] [Full Text] [Related]
10. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine]. Saeki T; Takashima S Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741 [TBL] [Abstract][Full Text] [Related]
11. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer. Aprile G; Mazzer M; Moroso S; Puglisi F Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178 [TBL] [Abstract][Full Text] [Related]
12. The role of capecitabine in the treatment of colorectal cancer in the elderly. Pasetto LM; Monfardini S Anticancer Res; 2006; 26(3B):2381-6. PubMed ID: 16821620 [TBL] [Abstract][Full Text] [Related]
13. Capecitabine in the treatment of colorectal cancer. O'Neill VJ; Cassidy J Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988 [TBL] [Abstract][Full Text] [Related]
14. First-line capecitabine is as effective as 5-fluorouracil/leucovorin in treating advanced colorectal cancer. Gambill BD Clin Colorectal Cancer; 2001 May; 1(1):18-9. PubMed ID: 12445375 [No Abstract] [Full Text] [Related]
15. Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer. Morse MA IDrugs; 2005 Dec; 8(12):974-7. PubMed ID: 16320126 [No Abstract] [Full Text] [Related]
16. A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes. Farkouh A; Ettlinger D; Schueller J; Georgopoulos A; Scheithauer W; Czejka M Anticancer Res; 2010 Dec; 30(12):5207-11. PubMed ID: 21187514 [TBL] [Abstract][Full Text] [Related]
17. [Capecitabine: an oral chemotherapeutic agent against metastatic breast and colorectal cancer]. Calzas Rodríguez J; de la Nogal Fernández B; Arrieta Garmendia JM; Lastra Aras E; García Castaño A; Barrio Gil-Fournier A; García Girón C Farm Hosp; 2003; 27(3):171-8. PubMed ID: 12835819 [TBL] [Abstract][Full Text] [Related]
18. [The prevention of diarrhea while under capecitabine therapy]. Grouls V Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410 [No Abstract] [Full Text] [Related]
19. [Capecitabine--a review of its antitumor activity and toxicity in clinical studies]. Sasaki T; Maeda Y Gan To Kagaku Ryoho; 2000 Jul; 27(8):1307-13. PubMed ID: 10945031 [TBL] [Abstract][Full Text] [Related]
20. The use of capecitabine in cancer: management of the hand foot syndrome. Sudoyo AW Acta Med Indones; 2005; 37(3):174-6. PubMed ID: 16110178 [No Abstract] [Full Text] [Related] [Next] [New Search]